Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06585865 · ClinicalTrials.gov registry record · NA

Strength Training and Resveratrol

A NA study of Sarcopenia and Anabolic Resistance, sponsored by Texas Tech University.

Recruiting
Registry status
NA
Development phase
36
Enrollment target
1
Study location

NCT06585865 is a NA study of Sarcopenia and Anabolic Resistance that is actively recruiting participants, run by Texas Tech University. The registered enrollment target is 36 participants, below the 80-participant average among 41 other Sarcopenia trials with a reported enrollment target (55% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06585865, a NA study of Sarcopenia and Anabolic Resistance, is actively recruiting participants, sponsored by Texas Tech University.

RECRUITING
Registry status
NA
Development phase
36 participants
Enrollment target
1
Study location

Study Summary

The main goal of this study is to find out if supplementing with resveratrol improves skeletal muscle adaptations to strengthening exercise (resistance training or strength training) in adults age 60+, and to determine whether circulating vehicles of inter-organ communication (extracellular vesicles) and their cargo might help explain those responses. The investigators will also examine whether resveratrol supplementation improves blood vessel function and cognitive function (brain health) in response to strength training.

Interventions

  • DIETARY_SUPPLEMENT Placebo
  • BEHAVIORAL Resistance training
  • DIETARY_SUPPLEMENT Resveratrol 500 mg oral once daily.

Study Locations (1)

Texas

  • Department of Kinesiology & Sport Management, Texas Tech University - Lubbock

Trial Details

FieldValue
Enrollment Target 36 participants
Start Date 2025-06-13
Est. Completion 2026-08
Phase NA

Sponsor

Texas Tech University

69 total trials

What the Registry Record Tells You About NCT06585865

The ClinicalTrials.gov registry entry for NCT06585865 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 36 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 80-participant average among 41 other Sarcopenia trials with a reported enrollment target (55% lower). The listed sponsor is Texas Tech University, which has 69 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Sarcopenia appearing as the primary indexed condition, and to 3 interventions - of which Placebo is the first listed.

NCT06585865 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.

Frequently Asked Questions

What is clinical trial NCT06585865 about?

NCT06585865 is a clinical study titled "Strength Training and Resveratrol". The main goal of this study is to find out if supplementing with resveratrol improves skeletal muscle adaptations to strengthening exercise (resistance training or strength training) in adults age 60+, and to determine whether circulating vehicles of inter-organ communication (extracellular vesicles...

What is the current status of trial NCT06585865?

This trial is currently recruiting. It is a NA study. The enrollment target is 36 participants. The study started on 2025-06-13. Estimated completion is 2026-08.

What conditions does trial NCT06585865 study?

This clinical trial studies the following conditions: Sarcopenia, Anabolic Resistance.

What interventions are being tested in trial NCT06585865?

The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), Resistance training (BEHAVIORAL), Resveratrol 500 mg oral once daily. (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT06585865?

This trial is sponsored by Texas Tech University, which has 69 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06585865 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Sarcopenia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.